Form C - Offering Statement:
SEC Accession No. 0002008980-24-000001
Filing Date
2024-04-17
Accepted
2024-04-17 16:05:13
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 8606
2 PORTFOLIO ex99.pdf EX-99 150198831
3 FORM C form_c.pdf EX-99 9245833
  Complete submission text file 0002008980-24-000001.txt   219409962
Mailing Address 651, NORTH BROAD STREET, SUITE 201, MIDDLETOWN DE 19709
Business Address 651, NORTH BROAD STREET, SUITE 201, MIDDLETOWN DE 19709 (302) 451-9161
Rejuvine Life Sciences Inc (Filer) CIK: 0002008980 (see all company filings)

EIN.: 612079105 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-33995 | Film No.: 24850990